Grace Therapeutics, Inc. (GRCE) insider activity

Grace Therapeutics, Inc. (GRCE): 2 insider buys worth $158,601 and 0 sales reported in the last 90 days.

A 10%+ shareholder bought $117,408 of Grace Therapeutics, Inc. stock with their own money. A decent-sized purchase. (2026-10-26)
A 10%+ shareholder bought $41,193 of Grace Therapeutics, Inc. stock with their own money. A small purchase, so treat it as a mild signal. (2026-10-26)

Reported	Who	Stock	What	Amount	Source
2026-10-26	Opaleye Management Inc. 10% owner	GRCE Grace Therapeutics, Inc.	Bought	$117,408	SEC filing
2026-10-26	Opaleye Management Inc. 10% owner	GRCE Grace Therapeutics, Inc.	Bought	$41,193	SEC filing

All insider buys · Legends

TradeTrack shows public SEC filings for general information. It is not investment advice, an offer or a recommendation. Insiders buy and sell for many reasons, past results do not predict future results, and you can lose money.